Completion of Acquisition of BHI

1st February 2006

                         COMPLETION OF ACQUISITION OF                          
                        BOOTS HEALTHCARE INTERNATIONAL                         

Reckitt Benckiser plc (RB.L) today announced that the acquisition of Boots
Healthcare International (BHI) has been completed with effect from 1st February
2006.

Bart Becht, Chief Executive Officer of Reckitt Benckiser, commented today:-

'We are excited at getting ownership of BHI. It will give us a platform for
additional growth at very attractive margins. BHI brings three new Power Brands
in Nurofen, Strepsils and Clearasil whose distribution can be substantially
expanded over time. In 2006, our major focus for this business will be on
successful integration and extracting the promised synergies while gradually
preparing the business for growth.'

Reckitt Benckiser is due to announce preliminary results for 2005 on Wednesday
8th February.

For Further Information Reckitt Benckiser plc Tel [phone]
Fiona Fong Head of Corporate Communications (press calls)
Mark Wilson Corporate Controller & Investor Relations Manager (investor calls)

Tim Spratt Financial Dynamics telephone [phone]

Note for Editors
On 7th October 2005, Reckitt Benckiser announced the acquisition of Boots
Healthcare International (BHI) from Boots Group PLC for a consideration of £
1,926 million in cash. The revenues of the combined Health and Personal Care
business will exceed £1 billion, an increase of 80% and will represent c.25% of
the enlarged Reckitt Benckiser. BHI brings 3 powerful brands: Nurofen, one of
Europe's leading brands of analgesic and leading ibuprofen brands; Strepsils,
the global number 1 medicated sore throat brand and Clearasil, the global
number 1 anti acne brand, to combine with Reckitt Benckiser's Gaviscon and
Lemsip. The company will have a strong presence in the key categories of
analgesics, cough/cold/flu, upper gastro-intestinal and medicated skincare.

Reckitt Benckiser is the world leader in household cleaning, excluding laundry,
and has a major presence in health and personal care. The Company is truly
global, with over 60 operating companies and over 40 manufacturing facilities
worldwide and has sales in 180 countries. The Company employs 20,000 people
around the world. Reckitt Benckiser is headquartered in Slough just outside
London and is listed on the London stock exchange. With a market capitalization
of c.£13.5bn it ranks among the top 30 UK listed companies. Reckitt Benckiser
had net revenues of £3.87bn, operating profit of £770m, and net income of £586m
in 2004.